Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:2203-2215
doi: 10.1161/CIRCULATIONAHA.106.621391
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by White, C. J.
Right arrow Articles by Gray, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, C. J.
Right arrow Articles by Gray, W. A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Angioplasty
*Peripheral Arterial Disease
Related Collections
Right arrow Other arteriosclerosis
Right arrow Peripheral vascular disease
Right arrow Other Treatment

(Circulation. 2007;116:2203-2215.)
© 2007 American Heart Association, Inc.


Advances in Interventional Cardiology

Endovascular Therapies for Peripheral Arterial Disease

An Evidence-Based Review

Christopher J. White, MD; William A. Gray, MD

From the Department of Cardiology (C.J.W.), Ochsner Clinic Foundation, New Orleans, La, and Endovascular Services (W.A.G.), Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, NY.

Correspondence to Christopher J. White, MD, Chairman, Department of Cardiology, Ochsner Clinic Foundation, 1514 Jefferson Hwy, New Orleans, LA 70121-2483. E-mail cwhite{at}ochsner.org

Peripheral arterial disease is one manifestation of systemic atherosclerosis. The prevalence of peripheral arterial disease increases with the age of the population. It is important to remember the significant association of coincident coronary artery disease, which is the major cause of mortality in these patients. Remarkable technological advances in the past decade, along with patient preference, have shifted revascularization strategies from traditional open surgical approaches toward lower-morbidity percutaneous endovascular treatments. The availability of stents, more than any other advance, has fueled the growth of catheter-based procedures by improving the safety, durability, and predictability of percutaneous revascularization.


Key Words: claudication • angioplasty • stents • angiogenesis • peripheral vascular diseases




This article has been cited by other articles:


Home page
VASC ENDOVASCULAR SURGHome page
W. J. M. Derksen, B. A. N. Verhoeven, R. H. W. van de Mortel, F. L. Moll, and J.-P. P. M. de Vries
Risk Factors for Surgical-Site Infection Following Common Femoral Artery Endarterectomy
Vascular and Endovascular Surgery, February 1, 2009; 43(1): 69 - 75.
[Abstract] [PDF]